E
Ennio Tasciotti
Researcher at Houston Methodist Hospital
Publications - 216
Citations - 9469
Ennio Tasciotti is an academic researcher from Houston Methodist Hospital. The author has contributed to research in topics: Drug delivery & Tissue engineering. The author has an hindex of 42, co-authored 212 publications receiving 7526 citations. Previous affiliations of Ennio Tasciotti include University of Akron & Open University.
Papers
More filters
Journal ArticleDOI
Localized inhibition of P2X7R at the spinal cord injury site improves neurogenic bladder dysfunction by decreasing urothelial P2X3R expression in rats
Alvaro Munoz,Iman K. Yazdi,Xiufeng Tang,Carolina Rivera,Nima Taghipour,Robert G. Grossman,Timothy B. Boone,Ennio Tasciotti +7 more
TL;DR: Localized inhibition of P2X7R for two weeks can be associated with reduced number of microglia and attenuated bladder hyperexcitability mediated by downregulation of urothelial P2x3R in rats with neurogenic bladder dysfunction and independently of locomotor improvements.
Journal ArticleDOI
In Situ Reductive Synthesis of Structural Supported Gold Nanorods in Porous Silicon Particles for Multifunctional Nanovectors
Guixian Zhu,Jen-Tsai Liu,Yuzhen Wang,Dechen Zhang,Yi Guo,Ennio Tasciotti,Zhongbo Hu,Xuewu Liu +7 more
TL;DR: Porous silicon nanodisks (PSD) may be a promising injectable, multifunctional nanovector for biomedical application and surface-enhanced raman scattering (SERS) using PSD/AuNR as particle substrates was demonstrated.
Journal ArticleDOI
Composite microsphere-functionalized scaffold for the controlled release of small molecules in tissue engineering
TL;DR: The presented strategy establishes the basis of a versatile scaffold for the controlled release of small molecules and for culturing mesenchymal stem cells for regenerative medicine applications.
Journal ArticleDOI
Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow-derived counterparts
TL;DR: The data demonstrate that the isolation protocol identifies and validates mesenchymal stem cells with superior clonal, proliferative, and developmental potential from cortical bone compared to the bone marrow niche although marrow persists as the typical source for mesenchyl stem cells both in the literature and current pre-clinical therapies.
Journal ArticleDOI
Inflammation and Cancer: In Medio Stat Nano
Roberto Molinaro,Claudia Corbo,Megan Livingston,Michael Evangelopoulos,Alessandro Parodi,Christian Boada,Marco Agostini,Ennio Tasciotti +7 more
TL;DR: The role of inflammation in the different steps of tumor development and the strategies based on the use of nanoparticles that exploit the inflammatory pathways in order to selectively target the tumor-associated microenvironment for therapeutic and diagnostic purposes are discussed.